Brighton Jones’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
TM
Brighton Jones's LAB Position: Q3 2026 in Review
Brighton Jones sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 21,944 shares — an estimated $18.1K sold.
Brighton Jones first reported a position in LAB in Q1 2026 and held it in 2 quarters. The position peaked at $18.1K in Q2 2026. 79 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- Brighton Jones reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 21,944 Standard BioTools shares in Q3 2026, an estimated $18.1K.
- Brighton Jones first reported a position in Standard BioTools in Q1 2026 and held it in 2 quarters.
- Brighton Jones's Standard BioTools position peaked at $18.1K in Q2 2026.
- 79 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.